Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
International Journal of Medicinal Mushrooms
Impact-faktor: 1.423 5-jähriger Impact-Faktor: 1.525 SJR: 0.433 SNIP: 0.661 CiteScore™: 1.38

ISSN Druckformat: 1521-9437
ISSN Online: 1940-4344

Volumes:
Volumen 21, 2019 Volumen 20, 2018 Volumen 19, 2017 Volumen 18, 2016 Volumen 17, 2015 Volumen 16, 2014 Volumen 15, 2013 Volumen 14, 2012 Volumen 13, 2011 Volumen 12, 2010 Volumen 11, 2009 Volumen 10, 2008 Volumen 9, 2007 Volumen 8, 2006 Volumen 7, 2005 Volumen 6, 2004 Volumen 5, 2003 Volumen 4, 2002 Volumen 3, 2001 Volumen 2, 2000 Volumen 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.v1.i2.20
pages 121-138

Biomedicinal Triterpenoids of Ganoderma lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetideae)

Ha Won Kim
Department of Life Sciences, University of Seoul Dongdaemun-gu, Jennong-dong 90, Seoul 130-743, South Korea
Byong Kak Kim
College of Pharmacy Seoul National University Seoul 151-724; and Department of Life Science, University of Seoul, Seoul 130-743, South Korea

ABSTRAKT

The fruiting body of Ganoderma lucidum (Curt.: Fr.) P. Karst. has been considered as a panacea for all types of diseases as described 2000 years ago in Shen Nung's Herbal. The traditional medicinal properties of the fungus have been utilized as treatments for hepatopathy, nephritis, hypertension, hyperlipemia, arthritis, neurasthenia, insomnia, bronchitis, asthma, gastric ulcer, arteriosclerosis, and diabetes. Some of these efficacies, such as cytotoxicity on hepatoma cells; inhibition of platelet aggregation; inhibition of histamine release; and antihypertensive, hypocholesterolemic, and anti-HIV activities were scientifically proven by isolation of the corresponding components. Although various compounds such as polysaccharides, proteins, minerals, and sterols have been reported as components of this mushroom, triterpenoids are mainly responsible for the biological activities. As 119 triterpenoids were reported in this medicinal fungus during the last three decades, there is a need to review most of the structures reported and their medicinal activities. The lanostane-type triterpenoids have been divided into 10 groups according to their structural similarities and the known biological and medicinal activities are described.


Articles with similar content:

Medicinal Properties of Substances Occurring in Higher Basidiomycetes Mushrooms: Current Perspectives (Review)
International Journal of Medicinal Mushrooms, Vol.1, 1999, issue 1
Solomon P. Wasser, Alexander L. Weis
Probing Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Higher Basidiomycetes): A Bitter Mushroom with Amazing Health Benefits
International Journal of Medicinal Mushrooms, Vol.15, 2013, issue 2
Robinka Khajuria, Anil Kumar Sharma, Priya Batra
Ethnopharmacological Investigations of Phytochemical Constituents Isolated from the Genus Cuscuta
Critical Reviews™ in Eukaryotic Gene Expression, Vol.27, 2017, issue 2
Tahir Farooq, Muhammad Ibrahim, Irum Majeed, Bisharat Ali, Iqbal Hussain, Muhammad Sajid Hamid Akash, Kanwal Rehman
Therapeutic Effects of Substances Occurring in Higher Basidiomycetes Mushrooms: A Modern Perspective
Critical Reviews™ in Immunology, Vol.19, 1999, issue 1
Solomon P. Wasser, Alexander L. Weis
Development of an Antitumor Biological Response Modifier from Phellinus linteus (Berk. et Curt.) Teng (Aphyllophoromycetideae) (Review)
International Journal of Medicinal Mushrooms, Vol.2, 2000, issue 1
Takashi Mizuno